Market Research Report Store Repligen Corp (RGEN) - Pharmaceuticals & Healthcar | Page 4

Repligen Corp, Medical Devices Deals, 2011 to YTD 2017
9
Repligen Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
Repligen Corp, Pharmaceuticals & Healthcare, Deal Details
Partnerships
10
11
11
Refine Technology Enters Into Technology Integration Agreement With Thermo Fisher Scientific
11
Refine Technology Enters Into Co-Development Agreement With Wuhan Institute of Biological
Products
11
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology
Licensing Agreements
12
13
BioMarin Enters Into Licensing Agreement With Repligen For Histone Deacetylase Inhibitor Portfolio
13
Repligen Enters Into Licensing Agreement With UCI
Debt Offering
14
15
Repligen Raises USD115 Million in Public Offering of 2.125% Notes Due 2021
Asset Transactions
16
Innovate Biopharma to Acquire Assets Related to RG-1068 from Repligen
Acquisition
15
16
17
Repligen Acquires TangenX Technology from Novasep Holding for USD39 Million
Repligen Acquires Atoll from UV-Cap
18
Repligen Acquires Refine Technology for USD35.4 Million
19
Repligen Completes Acquisition Of Novozymes Biopharma For US$29 Million
Repligen Corp - Key Competitors 22
Key Employees
23
Locations And Subsidiaries 24
Head Office
24
20
17